Get the Stockscreener App
52.20
2.39%
-1.28
After Hours:
52.20
Haemonetics Corp stock is traded at $52.20, with a volume of 1.48M.
It is down -2.39% in the last 24 hours and down -0.06% over the past month.
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.
See More
Previous Close:
$53.48
Open:
$53.29
24h Volume:
1.48M
Relative Volume:
1.85
Market Cap:
$2.51B
Revenue:
$1.36B
Net Income/Loss:
$123.81M
P/E Ratio:
21.66
EPS:
2.41
Net Cash Flow:
$20.35M
1W Performance:
-4.01%
1M Performance:
-0.06%
6M Performance:
-20.52%
1Y Performance:
-28.75%
1-Day Range:
$51.87
$53.46
1-Week Range:
$51.87
$54.52
52-Week Range:
$50.68
$94.98
Haemonetics Corp Stock (HAE) Company Profile
Name
Haemonetics Corp
Sector
Industry
Phone
(781) 848-7100
Address
125 SUMMER STREET, BOSTON, MA
Compare HAE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HAE
Haemonetics Corp
|
52.20 | 2.59B | 1.36B | 123.81M | 20.35M | 2.41 |
|
ABT
Abbott Laboratories
|
133.73 | 225.15B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.71 | 155.92B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
383.34 | 146.41B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
94.03 | 118.42B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
77.57 | 45.96B | 5.69B | 1.41B | 577.90M | 6.95 |
Haemonetics Corp Stock (HAE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-11-25 | Downgrade | Raymond James | Strong Buy → Outperform |
| Aug-08-25 | Reiterated | Barrington Research | Outperform |
| Aug-08-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-09-25 | Upgrade | Citigroup | Neutral → Buy |
| Jun-26-25 | Initiated | Robert W. Baird | Outperform |
| Feb-07-25 | Downgrade | BofA Securities | Neutral → Underperform |
| Dec-06-24 | Initiated | JP Morgan | Overweight |
| Nov-08-24 | Upgrade | Raymond James | Outperform → Strong Buy |
| Sep-13-24 | Initiated | CL King | Buy |
| Sep-11-24 | Initiated | BofA Securities | Neutral |
| Sep-10-24 | Initiated | BTIG Research | Buy |
| Jun-12-24 | Upgrade | Needham | Hold → Buy |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Jan-27-22 | Downgrade | Needham | Buy → Hold |
| Dec-15-21 | Downgrade | Citigroup | Buy → Neutral |
| Aug-17-21 | Resumed | Raymond James | Outperform |
| Jun-17-21 | Initiated | Citigroup | Buy |
| May-14-21 | Upgrade | CJS Securities | Market Perform → Market Outperform |
| Apr-20-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Apr-19-21 | Downgrade | CJS Securities | Market Outperform → Market Perform |
| Feb-03-21 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Jan-21-21 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Nov-05-20 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| May-06-20 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Mar-31-20 | Upgrade | CJS Securities | Market Perform → Market Outperform |
| Jan-10-20 | Initiated | Needham | Buy |
| Aug-07-19 | Reiterated | Barrington Research | Outperform |
| May-14-19 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-08-19 | Reiterated | Barrington Research | Outperform |
| Aug-09-18 | Reiterated | Barrington Research | Outperform |
| Feb-07-18 | Reiterated | Barrington Research | Outperform |
| Jan-02-18 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Nov-08-17 | Reiterated | Barrington Research | Outperform |
| Aug-08-17 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Jul-13-17 | Upgrade | JMP Securities | Mkt Perform → Mkt Outperform |
| Feb-07-17 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Nov-08-16 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Nov-07-16 | Reiterated | The Benchmark Company | Hold |
| Sep-20-16 | Downgrade | CJS Securities | Market Outperform → Market Perform |
| Aug-15-16 | Downgrade | Sidoti | Buy → Neutral |
| Aug-02-16 | Reiterated | Jefferies | Buy |
| Aug-02-16 | Reiterated | The Benchmark Company | Hold |
View All
Haemonetics Corp Stock (HAE) Latest News
Q1 EPS Estimates for Haemonetics Raised by Zacks Research - MarketBeat
Autotransfusion Systems Market Set for Rising Demand and Strong - openPR.com
Zacks Research Predicts Haemonetics' Q1 Earnings (NYSE:HAE) - MarketBeat
Haemonetics Corporation (NYSE:HAE) Short Interest Up 41.9% in August - MarketBeat
Invenomic Capital Management LP Buys New Shares in Haemonetics Corporation $HAE - MarketBeat
RSI Alert: Haemonetics (HAE) Now Oversold - Nasdaq
Royal Bank of Canada Purchases 24,650 Shares of Haemonetics Corporation $HAE - MarketBeat
How sensitive is Haemonetics Corporation to inflation2025 Trading Recap & Free Low Drawdown Momentum Trade Ideas - Lancaster City Council
How moving averages guide Haemonetics Corporation tradingEarnings Risk Report & Long-Term Investment Growth Plans - Newser
What technical models suggest about Haemonetics Corporation’s comeback2025 Stock Rankings & Weekly Setup with ROI Potential - Newser
Ranking Haemonetics Corporation among high performing stocks via toolsGlobal Markets & Smart Money Movement Tracker - Newser
Can Haemonetics Corporation hit a new high this monthWeekly Market Report & AI Powered Buy and Sell Recommendations - Newser
Is Haemonetics Corporation stock ready for a breakoutPortfolio Performance Summary & Free Fast Gain Swing Trade Alerts - Newser
Intraday pattern recognizer results for Haemonetics CorporationM&A Rumor & Fast Exit Strategy with Risk Control - Newser
How sentiment analysis helps forecast Haemonetics CorporationQuarterly Earnings Summary & Fast Exit and Entry Strategy Plans - Newser
Will a bounce in Haemonetics Corporation offer an exitTrade Entry Report & Reliable Price Breakout Signals - Newser
Applying big data sentiment scoring on Haemonetics CorporationMarket Performance Summary & Risk Controlled Swing Alerts - Newser
Heatmap analysis for Haemonetics Corporation and competitorsMarket Trend Summary & Daily Stock Trend Reports - Newser
Will Haemonetics Corporation benefit from AI trendsJuly 2025 Price Swings & Intraday High Probability Alerts - beatles.ru
Cubist Systematic Strategies LLC Makes New Investment in Haemonetics Corporation $HAE - MarketBeat
Market reaction to Haemonetics Corporation’s recent news2025 Earnings Impact & Daily Volume Surge Trade Alerts - Newser
PDT Partners LLC Raises Position in Haemonetics Corporation $HAE - MarketBeat
Is this a good reentry point in Haemonetics Corporation2025 Market Outlook & Free Risk Controlled Daily Trade Plans - Newser
Does Haemonetics Corporation show high probability of reboundTrade Entry Report & Entry Point Strategy Guides - Newser
Risk adjusted return profile for Haemonetics Corporation analyzedWeekly Market Report & Reliable Price Breakout Signals - Newser
Does Haemonetics Corporation have strong EBITDA margins2025 Earnings Surprises & Daily Stock Momentum Reports - خودرو بانک
Does Haemonetics Corporation meet Warren Buffett’s criteriaJuly 2025 Setups & Accurate Technical Buy Alerts - خودرو بانک
Advanced analytics toolkit walkthrough for Haemonetics CorporationMarket Risk Analysis & Free Fast Gain Swing Trade Alerts - Newser
What moving averages say about Haemonetics CorporationPortfolio Performance Report & Low Drawdown Investment Strategies - Newser
What are the risks of holding Haemonetics CorporationJuly 2025 Snapshot & Pattern Based Trade Signal System - خودرو بانک
What candlestick patterns are forming on Haemonetics CorporationJuly 2025 Selloffs & Safe Entry Momentum Tips - Newser
Keeley Teton Advisors LLC Has $718,000 Position in Haemonetics Corporation $HAE - MarketBeat
Is Haemonetics Corporation a candidate for recovery playTrade Volume Summary & Weekly High Momentum Picks - Newser
Is Haemonetics Corporation a top pick in the sectorIndex Update & AI Based Buy/Sell Signal Reports - خودرو بانک
How to escape a deep drawdown in Haemonetics CorporationMarket Trend Summary & Entry Point Confirmation Alerts - Newser
Can Haemonetics Corporation reach all time highs this yearWeekly Trade Review & Daily Entry Point Trade Alerts - خودرو بانک
Published on: 2025-09-02 04:04:11 - Newser
Zacks Research Estimates Haemonetics' Q2 Earnings (NYSE:HAE) - MarketBeat
Can Haemonetics Corporation weather a recession2025 Trade Ideas & AI Driven Price Forecasts - خودرو بانک
Analyzing Haemonetics Corporation with multi timeframe chartsJuly 2025 Pullbacks & Risk Adjusted Buy/Sell Alerts - Newser
Does Haemonetics Corporation outperform in volatile markets2025 Dividend Review & Daily Oversold Bounce Ideas - خودرو بانک
Using Python tools to backtest Haemonetics Corporation strategiesLong Setup & Expert Verified Movement Alerts - Newser
Can machine learning forecast Haemonetics Corporation recoveryQuarterly Portfolio Report & Real-Time Buy Zone Alerts - Newser
Haemonetics Corporation $HAE Stock Position Raised by Invesco Ltd. - MarketBeat
Haemonetics Corp Stock (HAE) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.14%
1.01%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):